Endocrinologia Pediátrica
Estudo de coorte | Associação da tecnologia de reprodução assistida com o crescimento e a adiposidade dos descendentes desde a infância até o início da vida adulta.
2 Ago, 2022 | 12:58hComunicado de imprensa: Concerns about effects of fertility treatment on children’s development are unwarranted, large study suggest – University of Bristol
Comentário no Twitter
This cohort study found that differences in early growth and adiposity for people conceived via assisted reproductive technology (vs. naturally) were small and reduced with older age. @aelhak19 @DeborahLawlor2 https://t.co/hwdldN6yDf
— JAMA Network Open (@JAMANetworkOpen) July 26, 2022
Estudo mostra que a obesidade infantil está ocorrendo em uma frequência ainda maior, com maior gravidade e em idades menores.
12 Jul, 2022 | 11:33hComunicado de imprensa: Study finds childhood obesity occurring at greater frequency, with more severity and at younger ages – Emory University
Estudo original: Changes in the Incidence of Childhood Obesity – Pediatrics
M-A | Sobrepeso/obesidade na infância e risco de puberdade precoce.
22 Jun, 2022 | 21:02hEstudo relacionado: Patterns of Early Life Weight Gain and Female Onset of Puberty – Journal of the Endocrine Society
#ADA2022 – Estudo randomizado | Dulaglutida semanal para tratamento de jovens com diabetes tipo 2.
13 Jun, 2022 | 15:00hOnce-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comunicado de imprensa: Once Weekly Drug Helps Control Pediatric Type 2 Diabetes – American Diabetes Association
Comentário no Twitter
Trial compared once-weekly dulaglutide with placebo for glycemic control in youths with type 2 diabetes who may have been receiving metformin or basal insulin. Dulaglutide was superior at 26 weeks. #ADA2022 https://t.co/P6PubXvHOR pic.twitter.com/1JPIT5IyTe
— NEJM (@NEJM) June 4, 2022
M-A | Tempo de tela e índice de massa corpórea entre crianças e adolescentes.
13 Jun, 2022 | 14:14hConteúdos relacionados:
M-A: Global prevalence of meeting screen time guidelines among children 5 years and younger.
Media and Young Minds – American Academy of Pediatrics
Papel de bebidas açucaradas na epidemia global de obesidade e doenças crônicas.
6 Mai, 2022 | 17:21hThe role of sugar-sweetened beverages in the global epidemics of obesity and chronic diseases – Nature Reviews Endocrinology (se o acesso a este link for pago, tente este)
Estudo randomizado | Fentermina/topiramato para tratamento de obesidade na adolescência.
3 Mai, 2022 | 16:45hPhentermine/Topiramate for the Treatment of Adolescent Obesity – NEJM Evidence
Comentário no Twitter
This RCT evaluated phentermine/topiramate in adolescents ages 12 to <17 yrs with high BMIs over a 56 week period. At both mid- and top-doses, treatment significantly reduced BMI and waist circumference compared to placebo. https://t.co/HbCZOAlZPf@PedsEndoSociety #PedsEndo2022 pic.twitter.com/nB5juqxyA0
— NEJM Evidence (@NEJMEvidence) April 30, 2022
Análise | Mudando a variedade de comida e bebida disponíveis para dietas mais magras e verdes.
19 Abr, 2022 | 12:46hChanging the assortment of available food and drink for leaner, greener diets – The BMJ
Comunicado de imprensa: Changing products on offer in shops and restaurants can lead to leaner, greener diets – BMJ
Revisão | Desafios no manejo e avanços terapêuticos na hiperplasia adrenal congênita.
19 Abr, 2022 | 12:29hManagement challenges and therapeutic advances in congenital adrenal hyperplasia – Nature Reviews Endocrinology (se o acesso a este link for pago, tente este)
Comentário no Twitter
New content online: Management challenges and therapeutic advances in congenital adrenal hyperplasia https://t.co/RCH4mRmvYe pic.twitter.com/76Jm00ISV1
— Nature Reviews Endocrinology (@NatureRevEndo) April 11, 2022
Estudo randomizado | Dapagliflozina não trouxe melhora significativa para o controle glicêmico de crianças e jovens adultos com diabetes tipo 2.
14 Abr, 2022 | 17:42hEfficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study – The Lancet Diabetes & Endocrinology (link para o resumo – $ para o texto completo)